Thymmune Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Thymmune Therapeutics's estimated annual revenue is currently $1.6M per year.
- Thymmune Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Thymmune Therapeutics has 20 Employees.
- Thymmune Therapeutics grew their employee count by 67% last year.
Thymmune Therapeutics's People
| Name | Title | Email/Phone |
|---|
Thymmune Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Thymmune Therapeutics?
Thymmune Therapeutics is a preclinical biotechnology company based in Cambridge, MA applying proprietary insights in thymic engineering to develop and commercialize immune cell therapy products addressing significant opportunities with unmet clinical need across immunology. Building on work from leading labs, Thymmune has strong IP positioning and is backed by early investors and founders of successful high-profile biotechnology companies.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$1.6M
Revenue (est)
67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 20 | -9% | $69M |
#2 | $2.9M | 20 | N/A | N/A |
#3 | $1.5M | 20 | -47% | N/A |
#4 | $3.1M | 20 | 11% | N/A |
#5 | $2M | 20 | -13% | N/A |